EVAXION A/S (EVAX:NASDAQ)
$3.64 0.03 (0.831%)
Analysed EVAXION A/S (EVAX:NASDAQ) News Sources
European Equities Traded in the US as American Depositary Receipts Open Week Tracking Higher in Monday Trading
18-05-2026
yahoo.com
European Equities Traded in the US as American Depositary Receipts Decline in Monday Trading
01-06-2026
yahoo.com
European Equities Traded in the US as American Depositary Receipts Track Lower in Wednesday Trading
03-06-2026
yahoo.com
European Equities Traded in the US as American Depositary Receipts Rise in Thursday Trading
04-06-2026
yahoo.com
European Equities Traded in the US as American Depositary Receipts Start Week Higher in Monday Trading
08-06-2026
yahoo.com
European Equities Traded in the US as American Depositary Receipts Trend Lower in Tuesday Trading
10-06-2026
yahoo.com
Evaxion presents new preclinical data for EVX-04, an off-the-shelf therapeutic vaccine for acute myeloid leukemia
11-06-2026
yahoo.com
European Equities Traded in US as ADRs Rise in Thursday Trading
11-06-2026
yahoo.com
Evaxion receives Prix Galien UK Award for Best digital health solution
12-06-2026
yahoo.com
European Equities Traded in the US as American Depositary Receipts Increase in Friday Trading; Rise for Week
12-06-2026
yahoo.com
What is the current price of EVAXION A/S (EVAX:NASDAQ)?
The current price of EVAXION A/S (EVAX:NASDAQ) is $3.64.
EVAXION A/S (EVAX:NASDAQ) absolute price change since previous trading day?
The absolute price change of EVAXION A/S (EVAX:NASDAQ) since the previous trading day is $0.03.
EVAXION A/S (EVAX:NASDAQ) percentage price change since previous trading day?
The percentage price change of EVAXION A/S (EVAX:NASDAQ) since the previous trading day is 0.831%.
What is the most recent average sentiment score for EVAXION A/S (EVAX:NASDAQ)?
The most recent average sentiment score for EVAXION A/S (EVAX:NASDAQ) is 27 out of 100.
What is the most recent average sentiment for EVAXION A/S (EVAX:NASDAQ)?
The most recent sentiment for EVAXION A/S (EVAX:NASDAQ) is .
SEC-8K** Filing Available For EVAXION A/S (EVAX:NASDAQ)
** material developments that could impact a company's financial condition or stock price.
Author: MattELab
MattELab is the founder and lead developer of SentientMerchant. With a Computer Science and Quantitative Finance background from a T10 university, he brings over 6 years of expertise in NLP, programmatic SEO, and full-stack development to build highly scalable AI and FinTech solutions.